The global cell lysis market was valued at US$ 2,715.1 billion in 2017 and is expected to witness a CAGR of 8.6 % over the forecast period (2017–2025).
Cell lysis is used for protein extraction, it further has various applications. It is used in protein labelling and enzyme engineering. Moreover, cell-lysis is also vital to study protein-protein interaction, which aids in the growth of cell lysis market. Market players in the global cell lysis market are investing in research and development to launch improved products that are used in cell lysis procedure. Furthermore, growing demand of cell-based therapy for treatment of cancer is likely to propel growth of the cell lysis market. For instance, in 2017, Zymo Research Corp collaborated with Bertin Technologies to create real-time sample lysis step to carry out in one minute.
Request Here Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/741
Drivers:
Vigorous research and development in the genomics and proteomics field and increasing cases of cancer and infectious disease is expected to propel growth of the cell lysis market. For instance, in 2012, as per the EU Industrial R&D Investment scoreboard, 17.7% of R&D business expenditure was represented by biotechnology and pharmaceutical segment. Moreover, in 2017, the FDA granted approval to 2 CAR-T cell therapy to treat patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia.
Restraints:
High cost of cell-based research due to high expenditure in R&D for CAR-T cell therapy is expected to hinder growth of the market of cell lysis. For instance, the price of CAR T-Cell therapy approved by the FDA is US$475,000 for single infusion for young adults and pediatric patients with B-cell precursor acute lymphoblastic leukemia.
Rise in the number of cancer and infectious disease cases different regions is also expected to boost growth of the cell lysis market. For instance, in 2012, GLOBOCAN estimated new diagnosis of 850,000 cancer cases in Africa, while around 600,000 fatalities were caused due to malignant disease.
Moreover, in 2012, the World Health Organization (WHO) reported that parasitic disease infection caused around 3,319 deaths in Sub Saharan Africa and 8000 deaths were caused due to Ebola in 2014.
Market players are adopting various strategies such as collaboration with government, which is also expected to fuel growth of the cell lysis market over the forecast period. For instance, in September 2015, the Bill & Melinda Gates Foundation donated US$5.5 million seed funding to new partnership of Development (NEPAD) Agency of Africa and African Academy of Sciences (AAS).
Moreover, in 2016, Thermofisher scientific, Inc. collaborated with Hamilton Bonaduz AG, to speed up access of automation platform to foreinsic customers.
Get PDF Brochure with Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/741
Regional analysis:
Cell lysis market is regionally divided into North America, Europe, Latin America, Middle East, Asia Pacific, and Africa.
North America is expected to witness substantial growth in the cell lysis market, owing to growing cell-based research due to increasing demand for precision medications. For instance, in 2015, the Precision Medicine Initiative was introduced in the U.S. for the transformation of treatment of diseases, including cancer and other chronic diseases.
Moreover, Asia Pacific is expected to witness robust growth in the cell lysis market due to rising number of pharmaceutical companies and research laboratories with rising expenditure on R&D. for instance, in 2017, the expenditure on research and development in China augmented by 11.6% to US$ 280 billion.
In 2014, as per the 13th five year plan for national science and technology talent development (2016-2020), the yearly per capita expenditure of china on research and development will be increased from US$ 58,787 in 2014 to US$ 79,442 by the year 2020.
Key players:
Key players active in cell lysis market are Merck & Co. Inc., F. Hoffmann-La Roche Ltd, Dickinson and Company, Cell Signaling Technology, Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Becton, Bio-Rad Laboratories, Inc., and Qsonica
Reasons to Purchase this Report
• Current and future of global Cell Lysis market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Content
Global Cell Lysis Market Research Report
Section 1: Global Cell Lysis Industry Overview
Section 2: Global Economic Impact on Cell Lysis Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Cell Lysis Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837